Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Avista Public Acquisition Corp II Cl A (AHPA)

Avista Public Acquisition Corp II Cl A (AHPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 176,094
  • Shares Outstanding, K 28,750
  • Annual Sales, $ 0 K
  • Annual Income, $ -520 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AHPA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.83 +5.06%
on 11/01/22
10.50 -41.67%
on 10/27/22
-4.08 (-39.98%)
since 09/30/22
3-Month
5.83 +5.06%
on 11/01/22
10.50 -41.67%
on 10/27/22
-3.99 (-39.48%)
since 07/28/22
52-Week
5.83 +5.06%
on 11/01/22
10.50 -41.67%
on 10/27/22
-3.88 (-38.75%)
since 11/01/21

Most Recent Stories

More News
OmniAb Reports Third Quarter 2022 Financial Results and Business Highlights

OmniAb, Inc. (NASDAQ: OABI) reported financial results for the three and nine months ended September 30, 2022 and provided operating and program updates. OmniAb was part of Ligand Pharmaceuticals Incorporated...

OABI : 4.50 (+0.45%)
LGND : 85.29 (+1.45%)
AHPA : 6.13 (-9.26%)
OmniAb Announces Completion of Spin-Off and Business Combination

OmniAb, Inc. (NASDAQ: OABI) today announced the completion of the expected tax-free spin-off from Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and the subsequent business combination with Avista...

OABI : 4.50 (+0.45%)
LGND : 85.29 (+1.45%)
AHPA : 6.13 (-9.26%)
Ligand Announces that Janssen has Received Approval from U.S. FDA for TECVAYLIâ„¢ (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that Janssen Biotech, Inc. (Janssen) has received approval from the U.S. Food and Drug Administration (FDA) for TECVAYLI â„¢ (teclistamab)...

LGND : 85.29 (+1.45%)
AHPA : 6.13 (-9.26%)
OmniAb Business Combination Approved by APAC Shareholders

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced the business combination (Business Combination) of Avista Public Acquisition Corp. II (APAC) (NASDAQ: AHPA) and OmniAb, Inc. (OmniAb),...

LGND : 85.29 (+1.45%)
AHPA : 6.13 (-9.26%)
Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its board of directors has set October 26, 2022 as the record date (Record Date) for the dividend of shares of common stock of OmniAb,...

LGND : 85.29 (+1.45%)
AHPA : 6.13 (-9.26%)
Avista Public Acquisition Corp. II Announces Effectiveness of Registration Statement and Sets Date for Extraordinary General Meeting to Vote on Proposed Business Combination

/PRNewswire/ -- Avista Public Acquisition Corp. II (NASDAQ: AHPA) ("APAC") announced today the effectiveness of the Registration Statement on Form S-4 filed...

AHPA : 6.13 (-9.26%)
Ligand Announces that Janssen has Received Approval from European Commission for TECVAYLI® (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that the Janssen Biotech, Inc. (Janssen) received conditional marketing authorization (CMA) from the European Commission for TECVAYLI ® (teclistamab)...

LGND : 85.29 (+1.45%)
AHPA : 6.13 (-9.26%)
Ligand Reports Second Quarter 2022 Financial Results

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and six months ended June 30, 2022 and provided an operating forecast and program updates. Ligand management...

LGND : 85.29 (+1.45%)
AHPA : 6.13 (-9.26%)
Ligand (LGND) Q1 Earnings Beat, OmniAb Spin-Off on Track

Ligand (LGND) reports encouraging first-quarter 2022 numbers by beating estimates on both counts. However, Captisol sales get hurt by lower demand for COVID-19 therapies.

AMGN : 311.41 (+0.96%)
GILD : 67.65 (+0.16%)
LGND : 85.29 (+1.45%)
AHPA : 6.13 (-9.26%)
Ligand Reports First Quarter 2022 Financial Results

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2022 and provided an operating forecast and program updates. Ligand management...

LGND : 85.29 (+1.45%)
AHPA : 6.13 (-9.26%)

Business Summary

Avista Public Acquisition Corp. II entered in definitive merger agreement with Ligand Pharmaceuticals Incorporated.

See More

Key Turning Points

3rd Resistance Point 8.31
2nd Resistance Point 7.76
1st Resistance Point 6.94
Last Price 6.13
1st Support Level 5.57
2nd Support Level 5.01
3rd Support Level 4.20

See More

52-Week High 10.50
Fibonacci 61.8% 8.72
Fibonacci 50% 8.16
Fibonacci 38.2% 7.61
Last Price 6.13
52-Week Low 5.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar